hit counter

Ketamine Increases Amygdala Volume in Treatment-Resistant Depression (TRD) (2024 MRI Study)

Depression is a complex mental health condition that significantly affects an individual’s emotional and physical well-being. Recent advances in neuroimaging have provided deeper insights into how major depressive disorder (MDD) alters brain structures, particularly the hippocampus and amygdala, and how treatments like ketamine can potentially reverse these changes. A new study using 3T and 7T …

Read more

Nortriptyline-Induced “Room Tilt Illusion”: A Rare Adverse Event of Antidepressants (2024 Case Report)

Room Tilt Illusion (RTI) presents a perplexing challenge to both patients and physicians, transforming the familiar into the surreal as surroundings appear rotated or flipped. This rare condition, often linked to neurological or vestibular disorders, has recently been observed as an adverse effect of the antidepressant nortriptyline, used in treatment-resistant depression. A case report highlights …

Read more

Empagliflozin for Depression: Effective Adjunct with SSRIs (2024 Clinical Trial)

Major Depressive Disorder (MDD) impacts millions globally, making it a significant public health challenge. Traditional treatments like Selective Serotonin Reuptake Inhibitors (SSRIs) don’t work for everyone, highlighting the need for innovative approaches. Recent clinical trials exploring the use of empagliflozin, a medication originally used to lower blood sugar in diabetes patients, have shown promising results …

Read more

Pharmaceutical & Recreational Drug Use During & After COVID-19 Pandemic (2020-2023 in Latvia) (2024 Study)

The COVID-19 pandemic has undeniably transformed various facets of human life, including our health behaviors and substance consumption patterns. Through the lens of wastewater-based epidemiology (WBE), a study conducted in Riga, Latvia, from December 2020 to July 2023, sheds light on how the pandemic and subsequent restrictions have impacted the use of pharmaceuticals and recreational …

Read more

Myo-Inositol for Traumatic Brain Injury (TBI): Targeting BATF2 for Epigenetic & Transcriptomic Changes (2024 Study)

Traumatic brain injury (TBI) remains one of the most challenging conditions for modern neurology, carrying a wide range of long-term consequences that can significantly impair an individual’s quality of life. In a new study, researchers analyzed the epigenetic landscape post-TBI, revealing significant DNA methylation changes in the hippocampus—a crucial area for memory and learning. The …

Read more

EPA & DHA Treat Depression in Mouse Models of Ulcerative Colitis (UC) (2024 Study)

Recent research has uncovered significant insights into the intersection of physical and mental health, particularly focusing on the relationship between ulcerative colitis (UC) and depression. This study has delved into how two omega-3 fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), can alleviate depressive-like behavior in mice induced by UC. Through meticulous experimentation, it …

Read more

Cannabis Use Linked to Increased Risk of Anxiety Disorders (2024 Review)

The relationship between cannabis use (CU) and anxiety disorders (AD) is a topic of ongoing debate and research within the scientific community. While some studies suggest cannabis can have anxiolytic (anxiety-reducing) effects, others point to anxiogenic (anxiety-inducing) outcomes, especially with habitual use. This nuanced interplay between cannabis and anxiety highlights the importance of understanding individual …

Read more